Residents of New York, New York, can now access Semaglutide (Ozempic / Wegovy) through Weight Method's fully virtual weight loss program. The fast-paced Northeastern lifestyle — long commutes, demanding schedules, and winters that limit outdoor activity — makes medically supported weight loss especially practical. Semaglutide is prescribed by licensed providers and shipped directly to your New York address.
FDA-approved Semaglutide prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · New York is already seeing results
Semaglutide in New York, NY: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Semaglutide to patients in New York from $297/month with virtual consultations and direct-to-door shipping.
For many people in New York, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide (Ozempic / Wegovy) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to New York residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Semaglutide shipped directly to your New York address. Average weight loss in clinical trials is 15-20% of body weight of body weight over 12-18 months.
In a diverse metropolitan area like New York, healthcare must meet patients where they are — linguistically and culturally. Weight Method prescribes Semaglutide with full bilingual support in English and Spanish, ensuring every patient understands their treatment plan, dosing schedule, and what to expect. This is not a translated afterthought; it is core to how we deliver Semaglutide in multicultural metros.
Clinically proven GLP-1 medications at transparent prices

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.
Consult with a licensed provider in New York and start Semaglutide from $297/month.
Get Started NowFree consultation. No commitment.